期刊文献+

应用沐舒坦佐治新生儿肺炎55例会体会

Application of Mu 55 Meeting Feel Comfortable George Neonatal Pneumonia
下载PDF
导出
摘要 目的观察沐舒坦(n=55)治疗新生儿肺炎的治疗效果。方法分析新生儿科于2008年1月~2012年5月收治新生儿肺炎100例,随机将100例新生儿肺炎患儿分为治疗组55例,采用沐舒坦治疗;对照组45例,采取常规治疗。结果治疗组与对照组总有效率经统计学检验,χ2=4.35,P〈0.05,差异有显著性,沐舒坦在改善呼吸症状、消除肺部体征优于对照组。结论沐舒坦治疗新生儿肺炎效果满意。未发现毒副作用。 Objective To observe the effect of ambroxol( n = 55) in the treatment of neonatal pneumonia treatment. Methods A retrospective analysis of neonatal department of our hospital from 2008. 1 ~ 2012. 5 were between neonatal pneumonia 100 cases,random 100 cases with neonatal pneumonia divided into treatment group( 55 cases),treated with Mucosolvin; 45 cases in the control group,take routine treatment. Results In the treatment group and the control group,the total effective rate of the statistical test,χ2= 4. 35,P〈0. 05,the difference was significant,Mucosolvan in improving respiratory symptoms,eliminate physical signs of the lungs is better than that of the control group. Conclusions The therapeutic effect of neonatal pneumonia with mucosolvan. No side effects were found.
作者 刘勇
出处 《航空航天医学杂志》 2016年第3期317-318,共2页 Journal of Aerospace medicine
关键词 沐舒坦 新生儿肺炎 体会 Soak up the comfortable Neonatal pneumonia Experience
  • 相关文献

参考文献3

二级参考文献27

  • 1朱科明,李深,邓小明.沐舒坦对危重患者肺功能的保护[J].中国急救医学,2001,21(1):59-60. 被引量:155
  • 2[1]Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med, 1998, 92:609-623.
  • 3[2]Teramoto S, Suzuki M, Ohga E, et al. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or with-out chronic obstructive pulmonary diseases. Pharmacology,1999, 59:135-141.
  • 4[3]Gillissen A, Bartling A, Schoen S, et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung, 1997, 175:235-242.
  • 5[4]Park NH, Han ES, Lee CS, et al. The inhibitory effect of ambroxol on respiratory burst, de granulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84: 81-87.
  • 6[5]Pfeifer S, Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. EurJ Med Res, 1997, 2:129-132.
  • 7[6]Stettner S, Ledwozyw A. The effect of Ambroxol on bleomycininduced changes in phospholipid composition of rat lung surfactant. Acta Physiol Hung, 1995, 83:181-187.
  • 8[7]Mira E, Benazzo M, De Paoli F, et al. Surfactants of the air-ways. Critical review and personal research. Acta Otorhinolaryngol Ital, 1997, 17(1 Suppl 56):3-16.
  • 9[8]Nemcekova E, Nosalova G, Franova S. Ambroxol and protective reflexes of the respiratory tract. Bratisl Lek Listy, 1998, 99:111-115.
  • 10[9]Tyrakowski T, Greczko Ⅰ, Sedlaczek A, et al. Electrophysiological investigation of the effects of ambroxol on the transepithelial Na + ion transport pathway in airways. Pol J Pharmacol,1998, 50:31-38.

共引文献490

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部